Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
TBPH
THERAVANCE BIOPHARMA INC
$14.400.70%3.45%9.51%33.95%54.01%77.34%43.28%-19.24%7.46%$14.55$7.881.03%82.74%0.64448,000-47.23%
RIGL
RIGEL PHARMACEUTICALS INC
$37.30-1.74%-8.74%-5.59%82.57%77.37%171.27%182.58%51.01%12.01%$43.72$13.3714.68%178.98%1.32743,00095.53%
BCRX
BIOCRYST PHARMACEUTICALS INC
$7.70-2.65%-5.98%-8.00%-25.17%-0.52%-2.65%-39.98%92.50%-41.22%$11.31$6.0231.92%28.01%1.223,124,000-2.31%
HALO
HALOZYME THERAPEUTICS INC
$76.33-0.74%0.63%13.47%41.56%21.25%21.33%80.32%177.26%318.02%$77.60$42.011.64%81.69%0.861,277,00013.92%
AUPH
AURINIA PHARMACEUTICALS INC
$12.810.55%4.15%4.40%57.37%52.50%79.66%69.00%-14.08%275.66%$12.90$6.550.70%95.57%1.091,177,000-14.02%
BMRN
BIOMARIN PHARMACEUTICAL INC
$53.14-1.76%-5.75%-7.65%-5.51%-25.73%-23.93%-39.68%-29.63%-59.71%$73.51$52.9327.71%0.40%0.741,829,000-5.23%
MDXG
MIMEDX GROUP INC
$6.970.43%-2.79%-1.97%16.36%-13.31%12.06%102.62%11.52%-32.59%$10.14$5.4731.26%27.42%1.23393,000-5.98%
PBYI
PUMA BIOTECHNOLOGY INC
$4.643.80%1.75%-19.02%34.49%43.21%84.13%81.25%-53.55%-95.45%$6.07$2.3223.56%100.00%1.00456,00020.95%
CRMD
CORMEDIX INC
$12.65-2.24%-0.78%-2.17%-11.79%20.82%79.18%262.46%176.81%-10.60%$17.43$5.6027.42%125.89%1.012,330,00037.63%
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
$36.56-1.46%-0.03%9.53%28.69%59.16%45.31%249.19%110.84%N/A$37.34$17.822.09%105.16%0.86562,00041.92%
MIRM
MIRUM PHARMACEUTICALS INC
$74.19-0.16%-4.13%9.22%47.14%64.32%83.55%223.69%250.95%N/A$78.10$36.865.00%101.28%0.75436,00029.76%
INVA
INNOVIVA INC
$19.550.93%-4.45%-6.55%-10.32%11.52%-2.45%56.90%74.55%92.99%$22.00$16.6711.14%17.28%0.46768,00023.08%
NAGE
NIAGEN BIOSCIENCE INC
$9.680.73%2.43%-3.39%-31.54%21.91%183.04%558.50%111.35%135.52%$14.69$3.1834.10%204.40%1.30675,000-20.77%
GMAB
GENMAB A
$27.990.61%1.63%20.08%22.44%34.57%5.30%-23.15%-24.41%186.49%$28.75$17.242.63%62.40%0.731,541,0003.84%
AKBA
AKEBIA THERAPEUTICS INC
$2.92-1.02%-6.71%-10.15%-18.44%21.67%108.57%689.19%10.61%-72.40%$4.08$1.2428.41%135.48%1.502,490,00010.47%
ONC
BEONE MEDICINES LTD
$332.272.44%-4.09%3.39%25.66%25.35%69.14%106.85%30.08%N/A$351.27$170.995.41%94.32%0.96356,00029.45%
XERS
XERIS BIOPHARMA HOLDINGS INC
$7.36-1.74%-5.28%-4.17%67.27%46.32%155.56%311.17%32.61%N/A$8.03$2.698.34%173.61%1.201,454,000-13.45%
INCY
INCYTE CORP
$83.140.05%-3.95%-4.35%16.74%34.08%25.19%20.53%-9.07%-36.76%$87.99$53.565.51%55.23%0.581,741,000-1.92%
LGND
LIGAND PHARMACEUTICALS INC
$165.52-0.14%-0.21%9.55%43.91%50.54%57.63%83.64%72.43%70.25%$169.49$93.582.35%76.87%1.12266,000-11.04%
XOMA
XOMA ROYALTY CORP
$37.861.18%7.10%20.69%56.00%82.63%32.38%107.22%82.37%118.64%$38.00$18.350.37%106.30%0.8727,000-5.92%
TVTX
TRAVERE THERAPEUTICS INC
$23.01-1.96%8.54%22.26%56.74%10.25%61.25%-15.40%17.88%-19.46%$28.69$12.9119.81%78.23%1.092,223,000-24.46%
ZYME
ZYMEWORKS INC
$15.931.21%4.87%10.93%25.93%26.63%27.34%195.00%-61.12%N/A$17.70$9.0310.00%76.41%0.97380,00012.76%
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$16.93-2.08%-2.31%0.24%26.34%3.11%66.63%-9.42%-32.50%N/A$18.15$8.036.72%110.83%1.221,169,000-16.92%
SLGL
SOL-GEL TECHNOLOGIES LTD
$23.98-3.35%-12.96%55.31%240.63%320.85%274.69%-58.75%-68.24%N/A$30.00$4.0120.07%498.60%0.556,600-50.00%
ALNY
ALNYLAM PHARMACEUTICALS INC
$461.14-1.02%1.34%2.72%49.34%82.19%70.56%121.19%253.34%327.97%$484.21$205.874.76%124.00%0.93907,00053.73%
VRTX
VERTEX PHARMACEUTICALS INC
$393.21-0.33%-0.52%0.11%-12.80%-23.46%-19.66%36.69%47.35%190.30%$519.88$362.5024.37%8.47%0.581,405,00043.66%
DOMH
DOMINARI HOLDINGS INC
$5.93-9.60%-2.63%-7.34%18.13%21.02%212.11%-7.20%-40.26%-99.23%$13.58$0.8356.33%617.92%1.19345,00069.95%
IONS
IONIS PHARMACEUTICALS INC
$61.10-3.26%0.16%39.56%73.38%78.13%50.12%28.66%15.44%10.73%$64.72$23.955.59%155.11%0.852,151,00046.23%
ABUS
ARBUTUS BIOPHARMA CORP
$4.531.57%10.76%34.62%26.54%38.11%6.34%96.10%54.08%-35.01%$5.10$2.7111.18%67.47%0.97968,000-42.72%
VCYT
VERACYTE INC
$31.873.21%-1.82%5.46%19.63%2.05%-5.23%62.60%-1.24%254.11%$47.32$22.6132.64%40.96%1.95712,00015.77%
IMAB
I-MAB
$3.62-11.49%-15.22%-25.67%43.65%325.88%241.51%-33.21%-90.47%N/A$5.90$0.6038.64%508.40%1.211,642,00019.42%
CPRX
CATALYST PHARMACEUTICALS INC
$19.76-1.05%-1.59%-2.32%-16.52%-9.40%-3.33%45.08%488.10%378.45%$26.58$19.1525.66%3.19%1.061,773,00069.18%
FBIO
FORTRESS BIOTECH INC
$3.55-8.74%-1.39%67.45%92.93%102.86%82.99%-77.02%-94.52%-91.95%$3.97$1.3310.58%167.92%1.17986,00035.63%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$32.500.34%-9.29%-11.85%-1.22%-5.30%-16.15%-27.68%-8.71%N/A$41.61$26.4721.89%22.78%0.86808,000-0.25%
FHTX
FOGHORN THERAPEUTICS INC
$4.99-3.85%-13.22%0.20%13.67%8.48%-46.11%-49.75%N/AN/A$10.25$2.9551.32%69.44%1.4999,00020.73%
LXRX
LEXICON PHARMACEUTICALS INC
$1.12-2.61%3.70%-9.68%67.16%191.67%-31.29%-58.21%-29.56%-92.01%$2.18$0.2848.51%294.37%1.411,715,0001.60%
CORT
CORCEPT THERAPEUTICS INC
$69.53-4.58%-2.39%-3.09%-1.93%20.13%80.74%174.82%292.38%1,290.60%$117.33$38.6840.74%79.76%0.87702,0005.56%
FENC
FENNEC PHARMACEUTICALS INC
$8.67-1.03%-3.88%3.71%6.12%37.18%66.73%29.02%42.13%327.09%$9.42$3.967.96%118.94%0.6937,700-5.75%
FOLD
AMICUS THERAPEUTICS INC
$7.73-3.25%-3.13%4.46%27.77%-15.24%-30.11%-29.41%-44.43%-57.60%$12.65$5.5138.89%40.29%1.023,394,00017.93%
ACAD
ACADIA PHARMACEUTICALS INC
$24.674.49%-2.84%-2.61%11.43%43.43%52.85%35.03%-36.40%-41.55%$26.65$13.407.43%84.10%0.912,783,00080.71%
ZVRA
ZEVRA THERAPEUTICS INC
$7.23-6.71%-13.21%-23.33%-20.77%-13.41%-7.07%5.55%-35.54%-97.98%$13.16$6.1945.06%16.80%0.841,300,000-28.34%
EXEL
EXELIXIS INC
$39.01-0.36%3.50%1.83%-6.56%5.38%42.01%127.73%55.23%528.18%$49.62$25.1721.38%54.96%0.632,334,000-5.74%
ASND
ASCENDIS PHARMA A
$194.62-0.49%-5.17%-1.87%9.52%15.27%39.44%78.08%36.58%886.42%$208.16$118.036.50%64.89%0.73225,000-0.88%
VCEL
VERICEL CORP
$31.42-2.36%-5.42%-13.40%-24.45%-33.99%-29.74%20.15%73.40%872.76%$63.00$30.2650.13%3.83%1.501,222,00049.21%
RPRX
ROYALTY PHARMA PLC
$35.15-3.33%-1.82%-3.30%0.14%6.45%24.38%-16.65%-13.65%N/A$38.00$24.057.50%46.15%0.524,694,00028.50%
JAZZ
JAZZ PHARMACEUTICALS PLC
$125.22-0.75%-3.57%6.33%14.21%-10.70%14.28%-17.72%-11.51%-22.35%$148.06$95.4915.42%31.13%0.73581,0003.75%
ARGX
ARGENX SE
$756.830.06%-1.45%15.75%37.30%23.22%40.69%99.07%224.43%N/A$779.03$510.062.85%48.38%0.66364,0007.37%
TGTX
TG THERAPEUTICS INC
$31.75-1.27%-1.95%13.07%-10.89%-22.67%27.56%334.93%25.84%169.75%$46.48$21.1631.69%50.05%1.901,907,000-20.08%
ATRA
ATARA BIOTHERAPEUTICS INC
$11.94-1.49%-1.97%-2.85%39.16%66.53%38.84%-89.84%-96.95%-98.95%$18.71$5.0136.17%138.56%1.8931,500-16.00%
OVID
OVID THERAPEUTICS INC
$1.281.59%3.23%31.96%339.86%174.68%9.40%-41.55%-80.03%N/A$1.47$0.2412.93%428.93%0.89876,00041.75%
TECH
BIO-TECHNE CORP
$51.620.70%-4.60%-3.69%-0.02%-17.51%-30.95%-34.74%-15.93%113.51%$80.95$46.0136.23%12.19%1.181,927,000-0.82%
VALN
VALNEVA SE
$8.93-0.11%4.81%-22.55%47.12%27.99%42.02%-47.69%N/AN/A$12.25$3.6227.10%146.69%1.0676,50091.25%
PTCT
PTC THERAPEUTICS INC
$58.98-3.45%3.56%20.81%13.71%3.17%74.65%9.93%23.93%58.80%$62.18$33.885.15%74.09%1.001,301,000-26.04%
MDGL
MADRIGAL PHARMACEUTICALS INC
$425.60-1.53%-6.21%15.08%49.30%24.28%82.36%511.49%298.05%504.98%$457.16$200.636.90%112.13%0.78265,00038.74%
ASMB
ASSEMBLY BIOSCIENCES INC
$21.19-3.02%-9.13%-16.71%22.91%100.09%15.48%-15.51%-90.06%-87.01%$27.17$7.7522.02%173.42%0.8979,00017.91%
FTRE
FORTREA HOLDINGS INC
$10.200.99%-1.16%26.87%76.17%2.20%-52.97%N/AN/AN/A$25.28$3.9759.65%156.93%1.581,236,000-16.66%
SPRO
SPERO THERAPEUTICS INC
$1.88-1.05%-5.76%-1.57%-34.04%143.84%37.23%93.81%-81.18%N/A$3.22$0.5141.61%272.28%0.77305,000-21.99%
MESO
MESOBLAST LTD
$15.464.32%6.25%-4.86%25.69%17.21%151.38%142.32%-56.33%N/A$22.00$6.0029.73%157.67%1.28163,000-12.37%
NTHI
NEONC TECHNOLOGIES HOLDINGS INC
$9.97-4.96%20.70%94.73%75.53%N/AN/AN/AN/AN/A$25.00$3.2060.12%211.56%-1.29109,000-43.23%
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$13.083.73%4.31%0.31%27.11%73.47%184.97%54.98%-71.53%N/A$13.68$3.984.39%228.56%2.001,462,000-25.03%
APLS
APELLIS PHARMACEUTICALS INC
$24.39-1.85%-9.36%-12.11%33.28%-2.87%-32.83%-62.33%-21.83%N/A$37.84$16.1035.54%51.49%1.023,169,00087.51%
REGN
REGENERON PHARMACEUTICALS INC
$572.592.25%2.53%-1.35%9.55%-15.60%-50.34%-18.88%-1.26%5.75%$1.17k$476.4950.89%20.17%0.62996,00065.17%
IMCR
IMMUNOCORE HOLDINGS PLC
$34.42-2.33%-6.06%4.68%4.59%14.58%4.30%-23.63%N/AN/A$39.33$23.1512.48%48.68%0.74137,000-25.95%
PLX
PROTALIX BIOTHERAPEUTICS INC
$1.915.52%20.89%29.05%33.57%-22.04%75.23%63.25%-45.74%-86.36%$3.10$0.9938.39%92.93%0.661,351,00048.79%
EVAX
EVAXION A
$2.92-0.85%-1.02%1.39%21.67%56.15%-82.03%-97.17%N/AN/A$16.69$1.2082.50%143.33%0.6024,800-36.08%
INBX
INHIBRX BIOSCIENCES INC
$27.19-1.22%-6.58%16.52%85.94%95.01%55.97%N/AN/AN/A$30.23$10.8110.07%151.60%0.9780,000-27.93%
RCUS
ARCUS BIOSCIENCES INC
$11.580.52%1.22%11.45%27.39%26.56%-31.48%-56.89%-45.40%N/A$18.98$6.5038.99%78.15%1.53585,000-4.41%
BDTX
BLACK DIAMOND THERAPEUTICS INC
$3.19-1.85%4.59%15.58%33.47%86.55%-41.14%21.76%-89.05%N/A$5.69$1.2043.94%166.95%1.53908,000-18.86%
GYRE
GYRE THERAPEUTICS INC
$7.900.89%0.13%-2.95%-1.62%-35.67%-43.81%-73.27%-89.05%-99.63%$19.00$6.1158.42%29.30%1.2755,600-25.87%
ZYBT
ZHENGYE BIOTECHNOLOGY HOLDING LTD
$10.6914.70%31.17%42.34%48.89%130.89%N/AN/AN/AN/A$14.30$3.5025.24%205.43%1.42229,000-21.31%
BNTX
BIONTECH SE
$97.881.18%-4.66%-13.78%-7.95%-2.95%-20.73%-32.09%46.26%N/A$131.49$81.2025.56%20.54%0.951,410,000-72.64%
KRYS
KRYSTAL BIOTECH INC
$155.718.37%7.24%3.62%17.04%-16.68%-19.85%118.42%236.96%N/A$207.84$122.8025.08%26.80%1.36798,000127.35%
SRPT
SAREPTA THERAPEUTICS INC
$17.470.46%-0.74%-19.90%-16.57%-82.76%-85.95%-84.22%-87.77%-54.21%$138.81$10.4287.41%67.74%0.895,132,00046.34%
ABEO
ABEONA THERAPEUTICS INC
$5.73-10.96%-14.55%-19.71%-4.02%8.02%7.41%40.66%-88.61%-95.59%$7.54$3.9324.07%45.56%0.772,218,00089.41%
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
$38.63-4.52%-5.87%-14.15%20.23%96.29%N/AN/AN/AN/A$48.45$17.0020.27%127.24%0.4910,90012.37%
AXSM
AXSOME THERAPEUTICS INC
$116.78-1.39%-9.68%6.92%14.83%-7.09%26.37%89.29%43.71%N/A$139.13$75.5616.07%54.55%0.95421,000-38.18%
IRD
OPUS GENETICS INC
$1.37-0.72%-2.14%14.17%45.59%45.44%5.38%-40.43%-82.44%-99.47%$1.75$0.6521.71%110.77%0.87149,000-54.29%
VRCA
VERRICA PHARMACEUTICALS INC
$4.944.00%-2.37%-17.11%-25.04%-24.06%-73.86%-87.00%-94.49%N/A$20.01$3.8275.31%29.45%0.9285,000388.51%
TARS
TARSUS PHARMACEUTICALS INC
$49.590.47%-12.83%-8.52%20.10%4.42%55.55%210.52%N/AN/A$59.76$30.2317.02%64.07%0.89867,000-29.28%
OKYO
OKYO PHARMA LTD
$2.09-2.79%-5.43%-21.13%-18.36%40.27%100.00%-32.03%N/AN/A$3.35$0.9037.59%131.71%0.4055,60035.61%
SLNO
SOLENO THERAPEUTICS INC
$51.17-4.57%-29.23%-28.56%-34.52%3.10%-3.07%2,280.00%60.91%-75.63%$90.32$41.5043.35%23.30%0.522,282,000-29.78%
PTHS
PELTHOS THERAPEUTICS INC
$33.001.57%2.61%57.44%170.49%96.43%288.24%N/AN/AN/A$54.29$4.5039.22%633.33%1.228,300-12.63%
KZIA
KAZIA THERAPEUTICS LTD
$7.99-0.13%-1.36%-0.56%-11.71%59.80%-53.00%-88.83%-97.78%-98.36%$39.05$2.8679.54%179.37%0.9732,800-60.95%
ENTA
ENANTA PHARMACEUTICALS INC
$7.46-9.90%-16.27%-6.75%2.47%22.30%-36.83%-87.12%-84.05%-82.28%$13.37$4.0944.20%82.40%0.94401,00079.02%
MNKD
MANNKIND CORP
$5.38-3.41%-3.41%44.24%41.21%2.67%-17.86%43.85%203.95%-70.11%$7.63$3.3829.49%59.12%1.126,169,00048.29%
NVO
NOVO NORDISK A S
$55.621.37%2.47%6.12%-27.78%-30.61%-59.37%7.78%63.78%98.22%$135.20$45.0558.86%23.46%0.6113,724,00033.20%
CVAC
CUREVAC NV
$5.360.37%0.19%-2.19%-2.90%74.59%63.91%-44.40%-90.05%N/A$5.72$2.376.29%126.16%1.20365,000-70.06%
RARE
ULTRAGENYX PHARMACEUTICAL INC
$29.00-4.32%-7.97%-2.32%-21.85%-26.84%-51.15%-38.66%-64.30%-76.57%$59.90$25.8151.59%12.36%1.091,994,00043.35%
ARWR
ARROWHEAD PHARMACEUTICALS INC
$28.67-3.53%5.52%39.79%82.61%83.78%40.20%-18.39%-15.18%309.57%$31.13$9.577.90%199.58%1.612,227,000-26.86%
CDTX
CIDARA THERAPEUTICS INC
$66.911.97%7.66%2.60%198.57%200.45%467.03%363.82%2.31%-77.80%$69.36$10.143.53%559.86%0.791,177,000210.55%
MAZE
MAZE THERAPEUTICS INC
$23.25-0.19%55.31%72.22%74.68%102.35%N/AN/AN/AN/A$25.50$6.718.82%246.50%0.90556,000-56.12%
TCRX
TSCAN THERAPEUTICS INC
$1.69-3.98%-10.11%-6.11%10.46%9.03%-70.56%-48.16%N/AN/A$6.23$1.0272.85%65.69%0.75308,00033.91%
PGEN
PRECIGEN INC
$3.59-5.28%-13.70%22.11%133.12%101.69%259.00%31.50%-32.07%-92.19%$5.23$0.6531.29%451.46%1.746,605,00022.45%
ZLAB
ZAI LAB LTD
$31.92-2.68%1.88%-10.66%-21.44%-16.77%54.35%-34.79%-59.49%N/A$44.34$20.1728.01%58.25%1.28489,000-48.90%
GERN
GERON CORP
$1.270.00%-7.30%-12.41%-18.06%-27.01%-70.94%-56.21%-31.35%-64.23%$4.83$1.0973.68%16.51%1.134,283,0000.66%
NRSN
NEUROSENSE THERAPEUTICS LTD
$1.16-4.92%0.00%-2.52%-52.65%-1.36%-13.43%-43.96%N/AN/A$2.60$0.8055.38%45.00%0.58551,000-74.12%
UTHR
UNITED THERAPEUTICS CORP
$403.11-0.47%2.15%28.74%39.70%24.83%16.85%82.70%281.19%160.22%$436.95$266.987.74%50.99%0.44695,00011.02%
MNPR
MONOPAR THERAPEUTICS
$54.4910.71%31.36%52.59%59.23%59.19%1,200.48%568.59%95.30%N/A$54.54$3.900.09%1,297.18%0.7043,30093.30%
NAMS
NEWAMSTERDAM PHARMA CO NV
$24.12-0.29%-3.87%-3.79%22.13%3.34%52.27%142.17%N/AN/A$27.35$14.0611.81%71.55%0.431,038,000-12.33%
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
$5.70-5.08%31.79%58.77%413.51%367.21%179.41%-19.24%-43.00%119.23%$6.26$0.648.95%790.63%0.41209,000-36.67%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)


Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)


Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)


Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)


Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.